04/03/2024
7:47 PM | Terns Pharmaceuticals (Issuer)
Vivo Capital Fund VIII, L.P. (Reporting)
Vivo Capital Surplus Fund VIII, L.P. (Reporting)
Vivo Capital VIII, LLC (Reporting)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:26 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2024
3:50 PM | Terns Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
5:01 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:02 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
7:38 PM | Terns Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:47 PM | Fairmount Funds Management LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
02/13/2024
10:44 AM | SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
3:20 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
01/25/2024
6:17 PM | Quirk Erin (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:17 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:18 PM | Terns Pharmaceuticals (Issuer)
Yoon Seokho Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
6:18 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
5:03 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
5:03 PM | Terns Pharmaceuticals (Issuer)
Yoon Seokho Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:10 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
3:33 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
8:09 AM | FIL Ltd (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/27/2023
3:32 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
06/14/2023
6:01 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:01 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:01 PM | GORDON CARL L (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:01 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:02 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:02 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:02 PM | Taylor Ann Elizabeth (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:36 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
3:44 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
8:01 AM | Terns Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
7:30 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
3:48 PM | Terns Pharmaceuticals (Filer)
| Form ARS | |
04/28/2023
3:25 PM | Terns Pharmaceuticals (Filer)
| Form DEF 14A | |
